RE:RE:RE:RE:RE:RS THOUGHTS !!I disagree. I think it is reasonable to assume that MCNA's throat would have been slit well before Priority Review if the ultimate intent was not to approve on Phase 3 A. Absolutely no political or financial reason to string a backwater biotech like Telesta along. There is no serious pharma sponsoring them, no major partner promoting them, not a single relevant financier backing them and from what I gather the entire management team are unknowns in US medical circles. What would possibly be the point of dragging this penny stock of never been-nobodies through the ringer? The question to me is how much can be done to rinse out the retail scum before the final approval. On the flip side who would care if Telesta and their MCNA brand disappeared, after a legally defensible fair shot, and died along the way?